PMID- 16039684 OWN - NLM STAT- MEDLINE DCOM- 20060501 LR - 20201209 IS - 0041-008X (Print) IS - 0041-008X (Linking) VI - 212 IP - 1 DP - 2006 Apr 1 TI - The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. PG - 14-23 AB - Langerhans cells (LC) are key mediators of contact allergenicity in the skin. However, no in vitro methods exist which are based on the activation process of LC to predict the sensitization potential of chemicals. In this study, we have evaluated the performances of MUTZ-3, a cytokine-dependent human monocytic cell line, in its response to sensitizers. First, we compared undifferentiated MUTZ-3 cells with several standard human cells such as THP-1, KG-1, HL-60, K-562, and U-937 in their response to the strong sensitizer DNCB and the irritant SDS by monitoring the expression levels of HLA-DR, CD54, and CD86 by flow cytometry. Only MUTZ-3 and THP-1 cells show a strong and specific response to sensitizer, while other cell lines showed very variable responses. Then, we tested MUTZ-3 cells against a wider panel of sensitizers and irritants on a broader spectrum of cell surface markers (HLA-DR, CD40, CD54, CD80, CD86, B7-H1, B7-H2, B7-DC). Of these markers, CD86 proved to be the most reliable since it detected all sensitizers, including benzocaine, a classical false negative in local lymph node assay (LLNA) but not irritants. We confirmed the MUTZ-3 response to DNCB by real-time PCR analysis. Taken together, our data suggest that undifferentiated MUTZ-3 cells may represent a valuable in vitro model for the screening of potential sensitizers. FAU - Azam, Philippe AU - Azam P AD - AFSSAPS, Unite BCM, 635 Rue de la Garenne, 34740 Vendargues, France. FAU - Peiffer, Jean-Luc AU - Peiffer JL FAU - Chamousset, Delphine AU - Chamousset D FAU - Tissier, Marie-Helene AU - Tissier MH FAU - Bonnet, Pierre-Antoine AU - Bonnet PA FAU - Vian, Laurence AU - Vian L FAU - Fabre, Isabelle AU - Fabre I FAU - Ourlin, Jean-Claude AU - Ourlin JC LA - eng PT - Journal Article DEP - 20050721 PL - United States TA - Toxicol Appl Pharmacol JT - Toxicology and applied pharmacology JID - 0416575 RN - 0 (Antigens, Surface) RN - 0 (B7-1 Antigen) RN - 0 (B7-2 Antigen) RN - 0 (CD40 Antigens) RN - 0 (Culture Media) RN - 0 (Cytokines) RN - 0 (Dinitrochlorobenzene) RN - 0 (HLA-DR Antigens) RN - 0 (Inducible T-Cell Co-Stimulator Ligand) RN - 0 (Irritants) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - 368GB5141J (Sodium Dodecyl Sulfate) RN - 63231-63-0 (RNA) SB - IM MH - Adult MH - Antigens, Surface/biosynthesis MH - B7-1 Antigen/pharmacology MH - B7-2 Antigen/genetics MH - CD40 Antigens/biosynthesis MH - Cell Differentiation/drug effects MH - Cell Line, Tumor MH - Culture Media MH - Cytokines/*physiology MH - Dermatitis, Contact/*physiopathology MH - Dinitrochlorobenzene/pharmacology MH - Drug Evaluation, Preclinical MH - Flow Cytometry MH - HLA-DR Antigens/genetics MH - Humans MH - Inducible T-Cell Co-Stimulator Ligand MH - Intercellular Adhesion Molecule-1/genetics MH - Irritants/pharmacology/*toxicity MH - Male MH - Predictive Value of Tests MH - RNA/biosynthesis/isolation & purification MH - Reverse Transcriptase Polymerase Chain Reaction MH - Sodium Dodecyl Sulfate/pharmacology MH - Up-Regulation/drug effects EDAT- 2005/07/26 09:00 MHDA- 2006/05/02 09:00 CRDT- 2005/07/26 09:00 PHST- 2005/03/01 00:00 [received] PHST- 2005/06/01 00:00 [revised] PHST- 2005/06/14 00:00 [accepted] PHST- 2005/07/26 09:00 [pubmed] PHST- 2006/05/02 09:00 [medline] PHST- 2005/07/26 09:00 [entrez] AID - S0041-008X(05)00383-2 [pii] AID - 10.1016/j.taap.2005.06.018 [doi] PST - ppublish SO - Toxicol Appl Pharmacol. 2006 Apr 1;212(1):14-23. doi: 10.1016/j.taap.2005.06.018. Epub 2005 Jul 21.